AstraZeneca

UK

Strong sterling key risk to pharma sector

When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.

clock 08 March 2019 • 2 min read

Markets

Woodford's reports £33.7m profit despite assets fall

Amid a tough period for fund performance

clock 09 January 2019 • 2 min read

UK

Woodford: 'Crowded consensus' in stockmarkets is about to change

Describes Prothena disappointment

clock 24 April 2018 • 2 min read

UK

Woodford slashes long-term holding in AstraZeneca

From top holding to 1% in 12 months

clock 25 March 2018 • 2 min read

Investment Trusts

Hargreaves Lansdown's five investment trusts to look out for in 2018

Key to maintaining a balanced approach

clock 25 January 2018 • 1 min read

UK

Woodford IM: Summer headwinds for Equity Income fund are beginning to reverse

Hurt by raft of share price falls

clock 19 October 2017 • 2 min read

Managed funds

Update: Jupiter Merlin team sells entire Woodford Equity Income stake

Reduced holding gradually over time

clock 11 October 2017 • 2 min read

UK

Ardevora's Lang: Why UK giants have suffered summer share price shocks

Firms seen double-digit falls

clock 31 August 2017 • 2 min read

Markets

Update: Woodford backs AstraZeneca as 'simply too cheap' despite £177m hit

Largest daily share price fall

clock 27 July 2017 • 5 min read

UK

Rathbones' Stick: Why we expect an uptick in pharma revenues

Previously warned on pharma dividends

clock 14 June 2017 • 2 min read
Trustpilot